<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="abstract"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Eur Psychiatry</journal-id><journal-id journal-id-type="iso-abbrev">Eur Psychiatry</journal-id><journal-id journal-id-type="publisher-id">EPA</journal-id><journal-title-group><journal-title>European Psychiatry</journal-title></journal-title-group><issn pub-type="ppub">0924-9338</issn><issn pub-type="epub">1778-3585</issn><publisher><publisher-name>Cambridge University Press</publisher-name><publisher-loc>Cambridge, UK</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmc">PMC11861170</article-id><article-id pub-id-type="doi">10.1192/j.eurpsy.2024.1326</article-id><article-id pub-id-type="other">EPV0675</article-id><article-id pub-id-type="pii">S0924933824013269</article-id><article-categories><subj-group subj-group-type="heading"><subject>Abstract</subject></subj-group><subj-group subj-group-type="section"><subject>e-Poster Viewing</subject></subj-group></article-categories><title-group><article-title>Factors associated with psychotropics adverse effects in elderly psychiatric inpatients</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Abid</surname><given-names>W.</given-names></name><xref rid="aff2948" ref-type="aff"/></contrib><contrib contrib-type="author"><name><surname>Turki</surname><given-names>M.</given-names></name><xref rid="aff2948" ref-type="aff"/></contrib><contrib contrib-type="author"><name><surname>Ben jmeaa</surname><given-names>B.</given-names></name><xref rid="aff2948" ref-type="aff"/></contrib><contrib contrib-type="author"><name><surname>Zribi</surname><given-names>A.</given-names></name><xref rid="aff2948" ref-type="aff"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Megdiche</surname><given-names>M. A.</given-names></name><xref rid="aff2948" ref-type="aff"/><xref rid="cor1178" ref-type="corresp">
<sup>*</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Ellouze</surname><given-names>S.</given-names></name><xref rid="aff2948" ref-type="aff"/></contrib><contrib contrib-type="author"><name><surname>Halouani</surname><given-names>N.</given-names></name><xref rid="aff2948" ref-type="aff"/></contrib><contrib contrib-type="author"><name><surname>Aloulou</surname><given-names>J.</given-names></name><xref rid="aff2948" ref-type="aff"/></contrib></contrib-group><aff id="aff2948">Psychiatry B department, <institution>Hedi chaker university hospital</institution>, <city>sfax</city>, <country>Tunisia</country></aff><author-notes><corresp id="cor1178"><label>*</label>Corresponding author.</corresp></author-notes><pub-date publication-format="electronic" date-type="collection" iso-8601-date="2024-04"><month>4</month><year>2024</year></pub-date><pub-date pub-type="epub"><day>27</day><month>8</month><year>2024</year></pub-date><volume>67</volume><issue seq="1301">Suppl 1</issue><issue-title content-type="special_issue">Abstracts of the 32nd European Congress of Psychiatry</issue-title><fpage>S639</fpage><lpage>S640</lpage><permissions><copyright-statement>&#x000a9; The Author(s) 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder>The Author(s)</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (<uri xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</uri>), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xlink:title="pdf" xlink:href="S0924933824013269a.pdf"/><abstract><sec id="sec7081"><title>Introduction</title><p>Adverse effects (AEs) of psychotropic drugs are more frequent and potentially more dangerous in elderly subjects (ES), probably due to a greater frequency of somatic comorbidities, as well as polymedication.</p></sec><sec id="sec7082"><title>Objectives</title><p>The aims of this study were to determine the prevalence of AEs of psychotropic treatment among ES hospitalized in psychiatry, and to identify the associated sociodemographic and clinical factors.</p></sec><sec id="sec7083"><title>Methods</title><p>
We conducted a retrospective and descriptive study. It concerned male patients aged at least 60 years, hospitalized in the psychiatry B department at CHU Hedi Chaker (Sfax, Tunisia) between 2018 and 2022. We collected demographic and clinical data from their medical records using a pre-established
form.</p></sec><sec id="sec7084"><title>Results</title><p>We included 30 patients. The average age was 64 years. Addictive behaviors were reported in 60%, and somatic histories were noted in 53.3% of patients. The three most frequent psychiatric diagnoses were schizophrenia (43.3%), bipolar disorder (33.3%) and depressive disorder (13.3%). Among our patients, 10% experienced adverse psychotropic drug reactions: orthostatic hypotension 6.7%; neurological AEs 3.3%. Univariate analysis showed no significant relationship between sociodemographic variables and psychotropic drug AEs. Patients with bipolar disorder were more likely to develop AEs of psychotropic treatment (p=0.04).</p></sec><sec id="sec7085"><title>Conclusions</title><p>Our results suggest that special attention should be paid to avoiding psychotropic medication AEs in psychiatric inpatients ES. Indeed, extra precautions need to be taken in this population due to their reduced ability to report their symptoms.</p></sec><sec id="sec7086"><title>Disclosure of Interest</title><p>None Declared</p></sec></abstract><counts><page-count count="2"/></counts></article-meta></front></article>